National Survey of Pre- and Post- Analytical Performance Measures Used in Newborn Screening Programs
|
|
|
- Virgil Howard
- 10 years ago
- Views:
Transcription
1 National Survey of Pre- and Post- Analytical Performance Measures Used in Newborn Screening Programs Simran Tiwana, MBA* Susan Tanksley, PhD* Brad Therrell, PhD Donna Williams, BS* Mirsa Douglass, MBA* Colleen Buechner, MS *= Texas Department of State Health Services = National Newborn Screening and Genetic Resource Center
2 Introduction Performance Measures: Objective way to measure the degree of success of a program in terms of its goals and objectives Number of clients served Change in attitude Change in knowledge etc. Performance Measures in Newborn Screening: Unsatisfactory rate Number of serious complications avoided Number of deaths avoided etc.
3 The Texas Newborn Screening Performance Measures Project Three year grant funded by the Centers for Disease Control (CDC) Primary objective to develop evidence-based pre- and post-analytical performance measures to improve the newborn screening system Inputs sought via this survey to help in development of performance measures
4 Survey Objectives To gather information on: Existing pre-analytical performance measures Existing post-analytical performance measures Agencies/organizations to whom performance measures are reported Frequency of reporting to external agencies/organizations Suggestions for future performance measures to improve the NBS system
5 Methods Web-based survey sent to all 50 States and District of Columbia Follow-up via telephone
6 Survey Questions Survey questions allowed structured as well as unstructured (qualitative) responses Example: Within your newborn screening program, which preanalytical performance measures are routinely recorded? The following list includes some common examples please be sure to list any additional measures related to pre-analytical phases of newborn screening. (Choose all options that apply) 1. Number of specimens classified as unsatisfactory because of poor specimen quality 2. Number of specimens classified as unsatisfactory because of insufficient or inaccurate data 3. Time from collection to receipt in the laboratory 4. Other (Please Specify)
7 Survey Responses States that Responded Alaska and Hawaii responded as well!
8 Results Number of surveys sent out = 51 Number completed = 35 Response rate = 68.62% Average time taken to complete survey = 11 minutes
9 Pre-analytical Performance Measures Recorded by State Laboratories (total 103 responses from 35 states) Not applicable = 0 Others = 10 Unsat due to poor specimen quality = 35 Time from collection to receipt in lab = 32 Unsat due to insufficient data = 26
10 Other Pre-analytical Measures Collected by States Measures related to time Time from birth until specimen collection Time from collection until receipt in the lab Turn-around time within the lab Time from birth until newborn screen result Measures related to errors in data Errors in demographic data entry Specimens drawn before 24 hours or after 7 days Measures related to missing data Missed screens Refused screens
11 Post-analytical Performance Measures Recorded by State Laboratories (88 responses from 35 states) Time from Not applicable = 1 Time from abnormal screen result until treatment initiation = 25 Others = 14 abnormal screen result until physician contact = 24 Time from abnormal screen result until physician confirms diagnosis = 24
12 Other Post-analytical Measures Collected by States Time-related Date of physician visit Date of first repeat screen Birth-defects registration date Date of treatment initiation Data on abnormal results Percent abnormal results followed Annual list of confirmed cases detected via screening
13 Reporting of Performance Measures (58 responses from 35 states) Not Applicable = 1 External stakeholders = 29 Internal reviewers/ executives = 28
14 Reporting of Performance Measures: Types of External Agencies (97 responses from 35 states) Others = 11 Not applicable = 3 National Database = 21 State Legislature = 6 Contracting agency =10 Advisory committee = 21 Healthcare provider/ birthing facility = 25
15 Other External Stakeholders Notified by State Programs Medical sub-specialists State Board of Health Newborn screening workgroups Annual report for distribution and on the newborn screening program website
16 Frequency of Reporting to External Agencies (56 responses from 35 states) Others = 8 Monthly = 15 Not applicable = 3 Annually =12 Quarterly =14 Bi-annually = 4
17 Performance Measures Suggested for Future Time-related Time from abnormal screen result to physician notification Time from receipt in lab until final result is obtained Transit time Specimen collection time Time from birth until receipt of screening report by medical home
18 Performance Measures Suggested for Future Disorder-specific Measures Number (%) of infants diagnosed with Sickle Cell Disease and treated before 2 months of age Number (%) of infants diagnosed with PKU and treated before 7 days of age Number (%) of patients with PKU where Phenylalanine levels were maintained in an acceptable range >80% of the time Specimen collected too soon for testing based on condition (e.g. PKU, MSUD, CH, CAH etc.)
19 Performance Measures Suggested for Future Measures related to specimen quality Unsatisfactory specimen rates Specimen card field completion rate Inadequate specimen rate Hospitals to be informed about number of unsatisfactory specimens etc.
20 Performance Measures Suggested for Future Measures related to demographic information/birth records Number (%) of births matched with screening records Number (%) of births with documented screening completed Demographic data errors
21 Performance Measures Suggested for Future Measures related to feedback Long-term follow-up for patient outcomes False negative rate False positive rate False positive rate with second tier testing Periodic distribution of educational materials to families Number (%) of diagnosed cases reported to national system as they are received (without waiting until a specific time) Number (%) lost to follow-up Number (%) no diagnosis for greater than one year
22 Conclusions Pre- and post-analytical measures collected by all states Disparity in: Types of measures collected Reporting agency Frequency of reporting Not many measures currently being collected on longterm outcomes Measures suggested for the future by some states are already being collected by other states Some suggestions for improvement could apply to all states Need for standardization and uniformity Suggested measures match with suggestions made by the TNSPMP stakeholders, validate those suggestions
23 Questions?
Texas Newborn Screening Performance Measures Project
Texas Newborn Screening Performance Measures Project Susan Tanksley, PhD MSGRCC Annual Meeting July 14, 2011 The Texas Newborn Screening Performance Measure Project (TNSPMP) is funded through a cooperative
HEALTH RESEARCH, INC. New York State Department of Health Wadsworth Center/Division of Genetics
HEALTH RESEARCH, INC. New York State Department of Health Wadsworth Center/Division of Genetics New York-Mid-Atlantic Consortium for Genetic and Newborn Screening Services Program Evaluation Consultant
Maryland State Sickle Cell Disease Follow Up Program SCDAA 41 st Annual Convention September 27, 2013
Maryland State Sickle Cell Disease Follow Up Program SCDAA 41 st Annual Convention September 27, 2013 Ms. Donna X. Harris Director Dr. Deborah Badawi, MD Medical Director Ms. Monika Piccardi RN, BSN Program
Overview of Hospital Utilization Review
Overview of Hospital Utilization Review Legal Authority The Inspector General (IG) hospital utilization review function operates under guidelines and regulations contained in: Texas Administrative Code
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER - SHREVEPORT MEDICAL RECORDS CONTENT/DOCUMENTATION
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER - SHREVEPORT MEDICAL RECORDS CONTENT/DOCUMENTATION Hospital Policy Manual Purpose: To define the components of the paper and electronic medical record
Sutter Health Support Services Shared Laboratory Position Description. Incumbent: Laboratory Date: October 23, 2006 Written By: Michele Leonard
Sutter Health Support Services Shared Laboratory Position Description Position Title: Clinical Laboratory Scientist, Microbiologist Incumbent: Entity: SHSS Shared Laboratory Reports To: Director of Operations,
Patient name; Patient address; Patient Social Security number/medical Record number; Patient date of birth; Patient phone number; Diagnosis code(s);
7 Billing The Sentara Reference Laboratory billing office is open Monday through Friday from 8:00 a.m. until 4:30 p.m. and can be reached by calling (757) 388-1985. Billing Representatives will be available
Newborn Screening Issues
Newborn Screening Issues - The Public Health Aspect - Dr. Helmut Brand Msc, MFPHM Institute of Public Health NRW, Bielefeld Public Health Genetics is like Mr Tur Tur, the phantom giant: the further you
Chapter 6 Case Ascertainment Methods
Chapter 6 Case Ascertainment Methods Table of Contents 6.1 Introduction...6-1 6.2 Terminology...6-2 6.3 General Surveillance Development...6-4 6.3.1 Plan and Document... 6-4 6.3.2 Identify Data Sources...
HIPAA Notice of Privacy Practices
HIPAA Notice of Privacy Practices THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY. This Notice
Laboratory Director Responsibilities
Clinical Laboratory Improvement Amendments (CLIA) Laboratory Director Responsibilities What Are My Responsibilities As A Laboratory Director NOTE: Congress passed the Clinical Laboratory Improvement Amendments
Health and Human Services Commission Department of State Health Services
Health and Human Services Commission Department of State Health Services Presentation to House Committee on Public Health February 17, 2015 Sonja Gaines, HHSC Associate Commissioner for Mental Health Coordination
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF ALASKA:
LAWS OF ALASKA 01 Source SB 1 Chapter No. AN ACT Relating to direct-entry midwives. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF ALASKA: THE ACT FOLLOWS ON PAGE 1 Enrolled SB 1 AN ACT 1 Relating to
A LEAN SIX SIGMA APPROACH TO CONTINUOUS QUALITY IMPROVEMENT IN THE TEXAS NEWBORN SCREENING PROGRAM
A LEAN SIX SIGMA APPROACH TO CONTINUOUS QUALITY IMPROVEMENT IN THE TEXAS NEWBORN SCREENING PROGRAM PATRICIA HUNT V. Telles, T. Odoms, P. Trevino Gonzales, A. Vinyard, L. Cao, S. Tupy, B. Reilly, P. Hunt,
Health Information Technology Survey for Newborn Screening Programs SUMMARY DATA REPORT
Health Information Technology Survey for Newborn Screening Programs SUMMARY DATA REPORT NOVEMBER 2014 The development of this report was 100% supported with federal funds from a $975,000 Cooperative Agreement
New Estimates of the Economic Benefits of Newborn Screening for Congenital Hypothyroidism in the US
The findings and conclusions in this presentation have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination
Wellness Consultation Policies. HIPAA Notice of Privacy Practices
Wellness Consultation Policies Cancellation Policy: There is a $50 charge for cancellations of less than 24 hours or failure to show up for a scheduled appointment. Email Policy: Email may be used for
REGISTRATION FORM. How would you like to receive health information? Electronic Paper In Person. Daytime Phone Preferred.
Signature Preferred Pharmacy Referral Info Emergency Contact Guarantor Information Patient Information Name (Last, First, MI) REGISTRATION FORM Today's Date Street Address City State Zip Gender M F SSN
Individualized Quality Control Plan
NOVEMBER 2014 CLIA Individualized Quality Control Plan WHAT IS AN IQCP? OVERVIEW Discovering, Deciphering and Designing an Individualized Quality Control Plan (IQCP) IQCP provides a framework for customizing
Policy and Procedure Manual
Policy and Procedure Manual Resident Assessment (RA) Table of Contents RA-01 RA-02 RA-03 RA-04 RA-05 RA-06 RA-07 RA-08 RA-09 RA-10 RA-11 RA-12 RA-13 Admission. History, Physicals and Routine Health Care
Newborn Screening Test
Important Information for Parents about the Newborn Screening Test Newborn Screening Branch Genetic Disease Screening Program http://cdph.ca.gov/nbs California Department of Public Health Publication Date:
LAP Audioconference How to Prepare and Comply with Your Quality Management Plan* February 18, 2009
LAP Audioconference How to Prepare and Comply with Your Quality Management Plan* February 18, 2009 Paul Bachner, MD, FCAP Professor & Chair Department of Pathology & Laboratory Medicine University of Kentucky
Examples: collecting the right sample on the right patient; labeling the sample accurately;
Quality Assessment: Basics & EMR is called by several names: and are just two of them. Quality Assessment (QA) is an on-going program designed to monitor and evaluate the quality or accuracy of all laboratory
GENETIC COUNSELING IS IT A CAREER FOR YOU? Judith L Miller, MS, LGC April 8, 2014
GENETIC COUNSELING IS IT A CAREER FOR YOU? Judith L Miller, MS, LGC April 8, 2014 What is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives. Most
HIPAA-ACKNOWLEDGEMENT OF RECEIPT Notice of Privacy Practices
PEDIATRIC ENDOCRINE ASSOCIATES, P.C. 8200 E. Belleview Avenue, Suite 510E Greenwood Village, CO 80111 303-783-3883 HIPAA-ACKNOWLEDGEMENT OF RECEIPT Notice of Privacy Practices Printed Patient Name: Patient
Maggie Dreon, MS, CGC Jessica Tarnowski
Communicating incidental findings of sickle cell trait on the newborn screen: A Community-Needs Based Assessment Minnesota Department of Health Newborn Screening Program Maggie Dreon, MS, CGC Jessica Tarnowski
This program is cosponsored by the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL).
PROFICIENCY TESTING TREC Quarterly Report Volume 4, No. 4 November 2014 INTRODUCTION This report is the Quarterly summary of all data reported within the specified data-reporting period for the Quarter
Contact Information: West Texas Health Information Technology Regional Extension Center 3601 4 th Street MS 6232 Lubbock, Texas 79424 806-743-1338
Contact Information: West Texas Health Information Technology Regional Extension Center 3601 4 th Street MS 6232 Lubbock, Texas 79424 806-743-1338 http://www.wtxhitrec.org/ Grant award - $6.6m Total number
The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011
The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011 Section 5: Screening, Treating and Reporting Chlamydia While the information
ADA-Sponsored Disability Income Protection Plan Application for Insurance
Members Insurance Plans ADA-Sponsored Disability Income Protection Plan Application for Insurance IPWS15 Read all forms Complete sections 1 thru 9 Mail or Fax ALL completed forms Questions? 866.607.5334
Medical Laboratory Technician AAS Program
Medical Laboratory Technician AAS Program New Program Proposal State Submission Steve Buchholz, Dean of Accreditation and Advancement July 2015 TABLE OF CONTENTS Executive Summary... 2 Identification and
504 Lavaca Street Suite 850 Austin, Texas 78701 PROVIDER NEWSLETTER
504 Lavaca Street Suite 850 Austin, Texas 78701 PROVIDER NEWSLETTER PROVIDER REPORT www.cenpatico.com Welcome to the first Cenpatico provider report for 2013. We re excited to share with you details on
Clinical Decision Making: Promoting Appropriate Reporting and Understanding of Molecular Genetic Test Results
Clinical Decision Making: Promoting Appropriate Reporting and Understanding of Molecular Genetic Test Results Maren Scheuner, MD, MPH, FACMG Lee Hilborne, MD, MPH, FASCP, DLM(ASCP) Ira M. Lubin, PhD, FACMG
Be your Own Consultant Checklist for Practice Manager
Be your Own Consultant Checklist for Practice Manager Telephones Are your phones routinely answered in less than three rings? Does your phone tree route your callers to the appropriate person who can assist
Home Office Use Only. Section B TYPE OF CLAIM: FIRST CLAIM CONTINUED CLAIM
Home Office Use Only CLAIM FORM AND INSTRUCTIONS If you have any questions regarding our determination of your claim, or if you would like to appeal any determination, please contact our Customer Care
2010 Laboratory Accreditation Program Audioconference. Accreditation Requirements for Waived Vs. Non-waived Tests
2010 Laboratory Accreditation Program Audioconference Accreditation Requirements for Waived Vs. Non-waived Tests Objectives: After participating in this audioconference you will be able to: Define the
http://english.gov.cn/laws/2005-08/24/content_25746.htm
Page 1 of 5 Measures for Implementation of the Law of the People's Republic of China on Maternal and Infant Care (Promulgated by Decree No.308 of the State Council of the People's Republic of China on
CLINICAL COURSE PROGRESSION AND CLINICAL REQUIREMENTS FOR FAMILY NURSE PRACTITIONER (FNP) STUDENTS
CLINICAL COURSE PROGRESSION AND CLINICAL REQUIREMENTS FOR FAMILY NURSE PRACTITIONER (FNP) STUDENTS Any licensed healthcare provider with the following qualifications may serve as a preceptor for a Nurse
Medical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives
Medical Laboratory Technology Program Student Learning Outcomes & Course Descriptions with Learning Objectives Medical Laboratory Technology Student Learning Outcomes All Colorado Mesa University associate
Using and Maintaining Documents and Records. Finding the information when you need it
Using and Maintaining Documents and Records Finding the information when you need it Problem Scenario You are the laboratory supervisor in a moderate-sized hospital. A physician calls you and says that
SMANN News! Volume 24 Issue 1
SMANN News! Volume 24 Issue 1 February 2014 Letter from the President January'starts'us'off'on'our'23 rd 'year'as'a'nann'chapter.'as'we'ended'2013'we'conducted'a'call'for'nomina>ons' to'fill'posi>ons'on'the'smann'board'of'directors.'at'the'november'holiday'dinner'we'confirmed'the'following'
Graduate Student Epidemiology Program
Graduate Student Epidemiology Program To promote training in MCH Epidemiology Real-World Experience in: Data Analysis and Monitoring Needs Assessment Program Evaluation 2015 Program Guide Submit your application
Public Health Reporting Initiative Functional Requirements Description
Public Health Reporting Initiative Functional Requirements Description 9/25/2012 1 Table of Contents 1.0 Preface and Introduction... 2 2.0 Initiative Overview... 3 2.1 Initiative Challenge Statement...
2009 LAP Audioconference Series. How to Prepare and Comply with Your Quality Management Plan
2009 LAP Audioconference Series How to Prepare and Comply with Your Quality Management Objectives: As a result of participating in this session, you will be able to: Explain the reasons why the QM is important
A Guideline for California From California Public Protection and Physician Health, Inc.
MAKING INFORMED CHOICES: Guidelines for Selecting Physician Health Services A Guideline for California From California Public Protection and Physician Health, Inc. CONTENTS INTRODUCTION 2 HOW PHYSICIAN
Patient Safety and the Laboratory
College of American Pathologists Laboratory Accreditation Program Patient Safety and the Laboratory May 21, 2008 Copyright 2008 College of American Pathologists (CAP). All rights are reserved. Participants
NewSTEPs Collaborative Improvement and Innovation Network (CoIIN) for Timeliness in Newborn Screening January 2015 - March 2016 Application Form
NewSTEPs Collaborative Improvement and Innovation Network (CoIIN) for Timeliness in Newborn Screening January 2015 - March 2016 Application Form PLEASE READ AND FOLLOW THESE APPLICATION INSTRUCTIONS: A
Improving Treatment for Children with Developmental Disabilities and Birth Defects
Improving Treatment for Children with Developmental Disabilities and Birth Defects Children with Special Health Care Needs Bureau Holly Williams, RN, MS, Director 2008 [email protected] The Bureau
DATE APPROVED: DATE EFFECTIVE: Date of Approval. REFERENCE NO. MOH/04 PAGE: 1 of 7
SOURCE: Ministry of Health DATE APPROVED: DATE EFFECTIVE: Date of Approval REPLACESPOLICY DATED: 1 POLICY TITLE: Incident/Accident Reporting REFERENCE NO. MOH/04 PAGE: 1 of 7 REVISION DATE(s): Ministry
Newborn screening sample collection guidelines
Newborn screening sample collection guidelines Detailed information about the newborn screening program, including correct sample collection techniques, can be found in the e-learning tool available at:
PROPOSAL. Proposal Name: Open Source software for improving Mother and Child Health Services in Pakistan". WHO- Pakistan, Health Information Cell.
PROPOSAL Proposal Name: Open Source software for improving Mother and Child Health Services in Pakistan". Submitted by: WHO- Pakistan, Health Information Cell. Please provide a description of the proposal
Appendix 6.2 Data Source Described in Detail Hospital Data Sets
Appendix 6.2 Data Source Described in Detail Hospital Data Sets Appendix 6.2 Data Source Described in Detail Hospital Data Sets Source or Site Hospital discharge data set Hospital admissions reporting
POLICYHOLDER. Policy No.(s): Waiver of Premium (include life policies) Routine Pregnancy
CLAIM FORM AND INSTRUCTIONS If you have any questions regarding our determination of your claim, or if you would like to appeal any determination, please contact our Customer Care Center at 1-800-348-4489
TOTAL PROCESS MANAGEMENT FOR YOUR NEWBORN SCREENING LABORATORY. Specimen Gate software
TOTAL PROCESS MANAGEMENT FOR YOUR NEWBORN SCREENING LABORATORY Specimen Gate software MANAGE YOUR ENTIRE SCREENING PROCESS Newborn screening generates vast amounts of data that require continuous tracking.
DACHDNC Follow-Up and Treatment Subcommittee September 20, 2013. Carol Greene, MD, Chair Christopher A. Kus, MD, MPH, Co-Chair
DACHDNC Follow-Up and Treatment Subcommittee September 20, 2013 Carol Greene, MD, Chair Christopher A. Kus, MD, MPH, Co-Chair 1 Follow-Up and Treatment Subcommittee Roster OFFICIAL MEMBERS Deborah Golant
Drug Testing to Support Pain Management
NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of
LAKE COUNTY SCHOOLS RECEIPT OF DRUG-FREE WORKPLACE POLICY
LAKE COUNTY SCHOOLS RECEIPT OF DRUG-FREE WORKPLACE POLICY I hereby acknowledge receipt of the Lake County School Board s Drug-Free Workplace Policy. I Understand that the name, address and telephone number
Thank you for making a reproductive genetic counseling appointment at the Mount Sinai Medical Center.
Division of Medical Genetics Department of Genetics and Genomic Sciences Mailing address: One Gustave L. Levy Place, Box 1497 New York, NY 10029-6574 Patient Address: 1428 Madison Avenue (at 99th Street)
ACCOUNTABLE CARE ANALYTICS: DEVELOPING A TRUSTED 360 DEGREE VIEW OF THE PATIENT
ACCOUNTABLE CARE ANALYTICS: DEVELOPING A TRUSTED 360 DEGREE VIEW OF THE PATIENT Accountable Care Analytics: Developing a Trusted 360 Degree View of the Patient Introduction Recent federal regulations have
Laboratory confirmation requires isolation of Bordetella pertussis or detection of B. pertussis nucleic acid, preferably from a nasopharyngeal swab.
Pertussis Epidemiology in New Zealand New Zealand has continued to experience outbreaks of pertussis in recent decades. This is in part due to historically low immunisation rates and in part because immunity
Advancing Health Equity. Through national health care quality standards
Advancing Health Equity Through national health care quality standards TABLE OF CONTENTS Stage 1 Requirements for Certified Electronic Health Records... 3 Proposed Stage 2 Requirements for Certified Electronic
Canadian Provincial and Territorial Early Hearing Detection and Intervention. (EHDI) Programs: PROGRESS REPORT
Canadian Provincial and Territorial Early Hearing Detection and Intervention (EHDI) Programs: PROGRESS REPORT www.sac-oac.ca www.canadianaudiology.ca 1 EHDI PROGRESS REPORT This progress report represents
Admission to the Second Degree BSCLS Program. Prerequisite Course Requirements for Second Degree BSCLS
Admission to the Second Degree BSCLS Program This is a 12 month online, second degree tract in clinical laboratory science for students who have completed a four-year science degree from an accredited
CDC CLIA-Related Initiatives to Improve Laboratory Practice A Key Component of Quality Health Care
CDC CLIA-Related Initiatives to Improve Laboratory Practice A Key Component of Quality Health Care Ira M. Lubin, PhD, FACMG Branch Chief (acting) Clinical Laboratory Improvement Advisory Committee Thursday,
children who are in a system of care for hearing loss as early as possible, the Mississippi
PROJECT NARRATIVE BACKGROUND AND NEED Screening, diagnosing, and early intervention for hearing loss as early as possible is crucial to a child s development. The first year of life is a critical period
Testimony of the American College of Nurse-Midwives. at a Hearing of the House Committee on Energy and Commerce Subcommittee on Health.
Testimony of the American College of Nurse-Midwives at a Hearing of the House Committee on Energy and Commerce Subcommittee on Health on the Improving Access to Maternity Care Act (H.R.1209) Wednesday,
Unique Standards and Documentation Required for Accredited CLT/MLT Programs
Unique Standards and Documentation Required for Accredited CLT/MLT Programs Section III (CLT/MLT) Page 1 UNIQUE STANDARDS AND THE REQUIRED DOCUMENTATION Objectives Clinical Laboratory Technician/Medical
RUBRIC ASSESSMENT: CERTIFIED SCHOOL NURSE (CSN) Date Self-Assessment Evaluator Assessment. Domain 1: Planning and Preparation
RUBRIC ASSESSMENT: CERTIFIED SCHOOL NURSE (CSN) Date Self-Assessment Evaluator Assessment Domain 1: Planning and Preparation Component Failing Needs Improvement Proficient Distinguished 1a: Demonstrating
RIDGE PHYSICAL THERAPY & WELLNESS CENTER. Intake Form
Intake Form : Personal Information please print clearly Name: last first middle initial Home Address: Home Telephone: ( ) Cell Phone: E-Mail Address: Social Security #: of Birth: Age: Sex: M F Marital